Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy
Olga Y. Gorlova(Dartmouth College), A T Lee(Feinstein Institute for Medical Research), Annemie J. Schuerwegh(Leiden University Medical Center), René Westhovens(KU Leuven), A. M. Hoffmann-Vold(Oslo University Hospital), Lina-Marcela Díaz-Gallo(Karolinska University Hospital), Marie Vanthuyne(Cliniques Universitaires Saint-Luc), John Varga(Michigan Medicine), Miguel Á. González‐Gay(Universidad de Cantabria), Leonid Padyukov(Karolinska University Hospital), Vanessa Smith(Ghent University Hospital), Roel A. Ophoff(University of California, Los Angeles), Roger Hesselstrand(Lund University), Alexandre E. Voskuyl(Amsterdam Neuroscience), Torsten Witte(Medizinische Hochschule Hannover), B. Koeleman(University Medical Center Utrecht), Jacob M. van Laar(University Medical Center Utrecht), Rajan Madhok(Glasgow Royal Infirmary), Plcm van Riel(Radboud University Nijmegen), Monique Hinchcliff(Yale University), Annet Italiaander(University Medical Center Utrecht), Paul G. Shiels(Midland Regional Hospital at Tullamore), Claudio Lunardi(University of Verona), Norberto Ortego‐Centeno, Patrícia Carreira, Filip De Keyser(Ghent University Hospital), Annika Nordin(Karolinska Institutet), Francisco José García Hernández(Hospital Universitario Virgen del Rocío), Paolo Airò(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Behrooz Z. Alizadeh(University Medical Center Groningen), J. Carlos Posada Simeón(Hospital Virgen del Valle), J M Martin(Consejo Superior de Investigaciones Científicas), Jane Worthington(Manchester Academic Health Science Centre), Paloma García de la Peña(Hospital Universitario Ramón y Cajal), Benedicte A. Lie(Oslo University Hospital), M M Chee(Glasgow Royal Infirmary), María Teruel(Consejo Superior de Investigaciones Científicas), N. Hunzelmann(University of Cologne), F. Houssiau(Cliniques Universitaires Saint-Luc), J. C. A. Broen(Radboud University Nijmegen), M.F. González‐Escribano(Institut Català d'Oncologia), Ruben van ‘t Slot(University Medical Center Utrecht), Jianming Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), R Scorza(University of Milan), V Fonollosa(Hospital Virgen del Valle)
Cited by 32
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
|Arthritis & Rheumatism|2005|1.5k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k